TOKYO —The numbers are startling: more than 3 million people in Japan suffer
from chronic hepatitis B or C, many over the age of 60. About 50% are
unaware they have the diseases, not having been screened. Globally,
viral hepatitis kills about 1.5 million people each year, as many as
The World Health Assembly of the World Health Organization (WHO)
recently passed a resolution aimed at getting countries to develop plans
for the screening, diagnosis and treatment of viral hepatitis. EURObiZ
Editor-in-chief Mike de Jong spoke with World Hepatitis Alliance
president Charles Gore and infectious disease control and prevention
specialist Dr Junko Tanaka of Hiroshima University about the screening
and treatment in Japan.
A new study by researchers at Weill Cornell Medical College in Qatar
(WCMC-Q) shows that there is a large geographic variation in the
distribution of the hepatitis C virus (HCV) in Egypt.
Egypt has the highest infection level of the disease in the world,
with 14.7% of the population carrying HCV, but it is still not clear why
this is so.
Treatment campaigns for bilharzia – a disease caused by parasitic
worms – during the 1960s and 1970s, using parenteral antischistosomal
therapy (PAT), contributed to the epidemic through wide-scale sharing of
needles and syringes. However, these campaigns can explain only about
10% of HCV infections in the country. It is probable that most HCV
infections in Egypt are linked to exposures in medical care settings.
Listen to excerpts from
interviews with Lucinda K. Porter and Alan Franciscus about their
personal struggles with hepatitis C and their advocacy efforts on Listen Live on WBEZ 91.5 Chicago Friday, August 22, 2014 at
4:44 PM and 6:20PM Central Daylight Time.
Pharmaceutical Benefits Scheme (PBS) will subsidise Olysio but not Sovaldi
simeprevir (Olysio) Hepatitis
Australia today welcomed the recommendation to add simeprevir (Olysio)
to the Pharmaceutical Benefits Scheme (PBS) for the treatment of
genotype 1 chronic hepatitis C.
sofosbuvir (Sovaldi) Responding
to the PBAC decision to reject an application to subsidise the
antiviral medication sofosbuvir (Sovaldi), Ms Tyrrell said “it’s a sad
day when access to game-changing therapy is denied. This is a bad
outcome for people living with hepatitis C”.
A Tulsa oral surgeon found to have possibly
exposed up to 5,000 patients to HIV, hepatitis B and hepatitis C may be
permanently barred from practicing as of Friday.
An agenda item for
the regular meeting of the Oklahoma State Board of Dentistry states
“discussion and possible action to accept permanent surrender of license
and agreed order” in the case against Dr. W. Scott Harrington. The
meeting is at 9 a.m. Friday in Oklahoma City.
In September last year, genetic testing confirmed that at least one
patient contracted hepatitis C from a visit to Harrington’s office. It
was the first documented report of patient-to-patient transmission of
hepatitis C in a dental setting in the United States.
There’s a cure for Hepatitis C, but it comes with a cost
Not many people who battle drug addiction and Hepatitis C live to
tell about it. Yet, 62-year-old Baltimorean and former county drug czar
Mike Gimbel fought and conquered both.
Gimbel, a former heroin addict, spent his teenage years leading a
double life. By day, he was a typical Jewish boy from Pikesville. By
night, he was scouring the streets of Baltimore for drugs. Nearly
bankrupting his family, Gimbel spent about $250 a day to satisfy his
“I had no idea what long-term damage I was doing to my body,” he said. “To be honest, I’m lucky I made it to 20.”
OraSure Technologies Inc. of Bethlehem
is kicking off a campaign with partner AbbVie pharmaceutical and the
Healthy Trucking Association of America to launch a Hepatitis C
awareness campaign in the trucking industry called Truckers Rolling
Against Hepatitis C.
They will be launching the campaign at the Great American Trucking
Show in Dallas on Thursday, and will be continuing with events across
the nation over the next several months.
According to Ron Ticho, senior vice president of corporate
communications at OraSure, professional truckers have more than five
times the risk of contracting Hepatitis C than the rest of the
population. He said the age demographic and lifestyle of the
professional trucking population puts it higher at risk.
students are suing a university after being put at risk of contracting
HIV and hepatitis when syringe components were wrongly reused during
blood tests and vaccinations for eight years.
University of Derby contacted 629 former and current students in April
after an investigation revealed potential ‘errors’ with vaccinations and
blood tests carried out by a healthcare worker.
is understood the worker incorrectly reused syringe barrels – putting
students at risk of viruses such as HIV, hepatitis B and hepatitis C –
between September 2005 and October 2013, although the needle was always
changed between patients.